Home > NRC Library > ADAMS Public Documents

Informs that review of decommissioning financial assurance submittal dtd 961009,1105 & 970509 completed.No further deficiencies identified.Return of numerous documents encl.

Accession Number: ML20147F697

Date Released: Monday, October 28, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20149D637 - Informs that review of decommissioning financial assurance submittal dtd 961009,1105 & 970509 completed.No further deficiencies identified.Return of numerous documents encl. (2 page(s), 7/7/1997)
• ML20149D716 - Forwards documents re control number 00210 for license 34-03643-10,held by Merrell Pharmaceuticals,Inc,subsidiary of Hoechst Marion Roussel,Inc.W/o encls. (1 page(s), 10/9/1996)
• ML20149D804 - Informs that firm guarantees,through parent company guarantee submitted to demonstrate compliance under 10CFR30, decommissioning of following facilities owned or operated by Merrell Dow Pharamaceuticals Inc,subsidiary of firm. (37 page(s), 5/22/1990)
• ML20149D755 - Informs that Marion Merrell Dow Inc,will provide corporate quarantees for Merrell Dow for financial assurances for decommissioning activities for two licensed facilities of Merrell Dow operating units,Merrell Dow Research Inst. (1 page(s), 3/24/1993)
• ML20149J584 - Forwards ICF Inc & OGC comments on nonstandard financial assurance submittals sent to NMSS for review by Merrell Dow Pharmaceuticals,Inc & Quanterra,Inc.W/o encls. (2 page(s), 9/20/1995)
• ML20149D760 - Certifies that Merrell Dow Pharmaceuticals Inc currently going concern & wholly-owned subsidiary of Marion Merrell Dow Inc,which consolidated w/subsidiaries,possesses positive tangible net worth.Firm not required to file form 10K. (1 page(s), 3/24/1993)
• ML20149D691 - Requests extension concerning request to amend stand by trust agreement & verification of authorized corporate signatures.Extension necessary to allow corporation legal staff addl time to prepare requested documentation. (13 page(s), 5/19/1997)
• ML20149D869 - Requests assistance in review of financial assurance in form of payment surety bond for Marion Merrell Dow,holder of license 34-03643-01. (1 page(s), 5/9/1996)
• ML20149D791 - Forwards documents related to decommissioning financial assurance for Merrell Dow Research Institute license 34-03643-01,submitted as required by 10CFR30. (2 page(s), 7/10/1990)
• ML20149D747 - Provides corporate guarantees for Merrell Dow for financial assurances for decommissioning activities for two licensed facilities of Merrell Dows operating units & Merrell Dow Research Institute. (1 page(s), 3/30/1994)
• ML20147F693 - Provides ICF & OGC comments for assistance in reviewing Merrell Pharmaceuticals nonstandard financial assurance submittals. (2 page(s), 3/12/1997)
• ML20149D744 - Certifies that Merrell Dow Pharmaceuticals Inc currently going concern & wholly-owned subsidiary of Marion Merrell Dow Inc,which consolidated w/subsidiaries,possesses positive tangible net worth.Firm not required to file form 10K. (2 page(s), 3/29/1994)
• ML20149D736 - Provides support for Marion Merrell Dow,Inc use of financial test to demonstrate financial assurance,per 10CFR30. (11 page(s), 3/28/1994)
• ML20149D781 - Informs that firm guarantees,through parent company, guarantee submitted to demonstrate compliance under 10CFR30, decommissioning of following facilities owned or operated by Merrell Dow Pharmaceuticals,Inc,subsidiary of firm. (8 page(s), 3/13/1992)
• ML20149L660 - Submits comments on non-standard financial assurance submittals. (2 page(s), 8/1/1996)
• ML20149D894 - Responds to 951031 ltr requesting several changes & or additions to decommissioning financial assurance documents previously submitted.New set of financial assurance documents encl. (22 page(s), 4/16/1996)
• ML20149D764 - Informs that firm guarantees,through parent company guarantee submitted to demonstrate compliance under 10CFR30, decommissioning of following facilities owned & operated by Merrell Dow Pharmaceuticals,Inc,subsidiary of firm. (11 page(s), 3/24/1993)
• ML20149D770 - Submits documents related to decommissioning financial assurances for Marion Merrell Dow Pharmaceuticals Inc, license 13-10064-01 being submitted as required by 10CFR30. (30 page(s), 5/15/1992)
• ML20149D640 - Informs that Merrell Dow Pharmaceuticals Inc,subsidiary of Marion Merrell Dow Inc & will provide guarantees for Merrell Dow for financial assurances for decommissioning activities for two licensed facilities of Merrell Dow operating units. (1 page(s), 3/30/1995)
• ML20149D654 - Informs that firm quarantees,through parent company guarantee submitted to demonstrate compliance under 10CFR30, decommissioning of Marion Merrell Dow Research Inst owned & operated by Merrell Dow Pharmaceuticals,Inc. (12 page(s), 3/29/1995)
• ML20149D695 - Requests addl info re review of 961009 financial assurance package. (2 page(s), 4/9/1997)
• ML20149D646 - Submits certification that Merrell Dow Pharmaceuticals Inc currently going concern & wholly-owned subsidiary of Marion Merrell Dow Inc.Ltr supports firm use of financial test to demonstrate financial assurance as specified in 10CFR30. (1 page(s), 3/29/1995)
• ML20149D720 - Submits response to 960830 request for addl info re financial assurance documents sent on 960416.On 961009 Lachmann submitted new set of financial assurance documents & should supersede 960416 submission. (14 page(s), 11/5/1996)
• ML20149D707 - Requests assistance in review of financial assurance documents submitted by Hoescht Marion Roussel Inc,license 34-03643-01. (1 page(s), 12/13/1996)
• ML20149D776 - Certifies that Merrell Dow Pharmaceuticals Inc,currently going concern & wholly-owned subsidiary of Marion Merrell Dow Inc which consolidated w/subsidiaries,possesses positive tangible net worth. (4 page(s), 3/18/1992)
• ML20149D728 - Certifies that on 910529,enclosed copies of standby trust agreement & amend to standby trust agreement executed & notarized by Commerce Bank of Kansas City,NA & Marion Merrell Dow Inc. (81 page(s), 11/5/1996)
• ML20149D913 - Requests addl info re decommissioning financial assurance instrument parent company guarantee/financial test dtd 950330. (4 page(s), 10/31/1995)
• ML20149D799 - Certifies that Merrell Dow Pharmaceuticals Inc,currently going concern & wholly-owned subsidiary of Marion Merrell Dow Inc,which consolidated w/subsidiaries,possesses positive tangible net worth.Firm not required to file form 10K. (1 page(s), 5/22/1990)
• ML20149D686 - Forwards modification to standby trust agreement & corporate signature authorization for license 34-03643-01.Control: 300210. (7 page(s), 6/4/1997)
• ML20149D702 - Discusses review of surety bond submitted by Merrell Pharmaceuticals,Inc & recommends NRC require licensee to modify submission. (13 page(s), 2/28/1997)
• ML20149D711 - Requests addl info re review of financial assurance documents dtd 960416. (4 page(s), 8/30/1996)
• ML20149D699 - Informs that OGC has no objection to comments under existing guidance in reg guide 3.66 re ICF comments on surety bond & standby trust agreement for Merrell Pharmaceuticals. (1 page(s), 3/12/1997)
• ML20149D947 - Submits review of parent company guarantee/financial test submitted by Merrell Dow Pharmaceuticals Inc. (10 page(s), 8/25/1995)
• ML20149D936 - Informs that OGC has no objections & no additions to ICF comments & recommendations on two submittals related to financial assurance for Merrell Dow Pharmaceuticals Inc. (1 page(s), 9/20/1995)
• ML20149D813 - Informs that no comments re review of nonstandard submittals for Merrell Pharmaceuticals. (14 page(s), 8/1/1996)
• ML20149D964 - Requests assistance in processing & review of non-standard financial assurance submittals related to decommissioning rule for Merrell Dow Research Inst,license 34-03643-01. (2 page(s), 7/5/1995)